Over the past five years, the bioscience industry in Delaware has undergone significant changes that were both negative and positive. Earlier this decade we lost about 12% of our jobs due to business decisions by ...
Movers, shakers, difference-makers Delaware has plenty of talented people, but who is set to make the biggest impact in 2019? Delaware Business Times asked industry leaders who they thought would be the biggest names in ...
By Dan Linehan Special to Delaware Business Times It’s natural to draw parallels between Kris Vaddi’s time discovering drugs at Incyte, where he spent 14 years, and his latest startup venture, Prelude Therapeutics. But there ...
A founding scientist and previous vice president of the pharmaceutical company Incyte is growing his next venture in Delaware. The state Council on Development Finance (CDF) voted Monday to recommend a performance-based grant package for Prelude Therapeutics. ...
Kris Vaddi has spent enough time in classrooms and laboratories to understand the power of discovery. More importantly, he knows that it cannot be ...
Digital media reporting: all Greek or all powerful? - A client once told me, “I don’t need to be bothered with digital media reports.”For digital media professionals, this statement stops the music,
The 5 E’s for B2B Content Marketing Success - Content marketing for B2B is different from B2C, and you should approach it with different goals in mind. Whereas B2C marketing can be full of flashy 
Instant Messaging Brings Rewards and Risks - Convenience and immediacy make instant messaging (IM) a popular collaboration tool. Underlying presence technology allows users to instantly see who
